HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,866 | -100.0% | 101,211 | -62.7% | 0.01% | -68.8% |
| Q3 2022 | $10,740,000 | +53.3% | 271,615 | +70.6% | 0.02% | +60.0% |
| Q2 2022 | $7,005,000 | -58.6% | 159,201 | -61.7% | 0.01% | -52.4% |
| Q3 2021 | $16,929,000 | +916.1% | 416,140 | +556.4% | 0.02% | +600.0% |
| Q3 2020 | $1,666,000 | +397.3% | 63,400 | +407.9% | 0.00% | +200.0% |
| Q2 2020 | $335,000 | -82.1% | 12,484 | -88.0% | 0.00% | -80.0% |
| Q1 2020 | $1,873,000 | -72.6% | 104,097 | -73.0% | 0.01% | -68.8% |
| Q4 2019 | $6,848,000 | +305.7% | 386,241 | +254.9% | 0.02% | +300.0% |
| Q3 2019 | $1,688,000 | +61.2% | 108,846 | +67.3% | 0.00% | +100.0% |
| Q1 2019 | $1,047,000 | -88.9% | 65,055 | -86.5% | 0.00% | -90.9% |
| Q1 2018 | $9,437,000 | +7103.8% | 481,718 | +4622.7% | 0.02% | – |
| Q2 2017 | $131,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |